Abstract
The expression of amylase in v histological types of thyroid canct studied by an immunohistochc technique, using a polyclonal amylase antiserum and two mono antibodies specific for salivary pancreatic Recently, Tomita et al, using molecular biological analysis, detected a novel type of human amylase in a lung carcinoid, which was encoded by the amy3 gene.'9 Interestingly, both medullary carcinoma of the thyroid gland and lung carcinoid tumour are regarded as neuroendocrine tumours histologically. Medullary carcinoma may therefore express this new amylase rather than pancreatic-type amylase.
Unfortunately, immunohistochemical analysis of the expression of amylase isoenzymes in lung carcinoid, using these specific monoclonal antibodies, has not been done. The monoclonal antibody 3B7 against pancreatic-type amylase cross-reacted with this novel amylase isoenzyme while the monoclonal antibody 88E8 against salivary-type amylase did not.'920 An antibody to differentiate the novel amylase isoenzyme encoded by the amy3 gene from pancreatic-type amylase has not been made as yet because the two are so similar. '920 On the other hand, the two different types of amylase-encoding genes, AMY2A and AMY2B, were expressed in normal human 212 pancreas. 22 While the former encodes "original" pancreatic-type amylase, the latter is identical with the amy3 gene.23 Accordingly, although histological localisation of this novel type of amylase isoenzyme has not been possible, it may be distributed not only in neuroendocrine tumours but also in normal tissues, including neuroendocrine cells or epithelial cells. In fact, Samuelson et al provided evidence that normal liver tissues also contain mRNA of the amy3 gene.24 The distribution of the amy3 gene product needs to be elucidated.
In conclusion, we have shown that most thyroid cancers produced amylase. Moreover, medullary carcinomas were immunoreactive for pancreatic-type amylase whereas other histological types were immunoreactive for salivary-type amylase. To elucidate the type of amylase isoenzyme in thyroid cancer molecular biological analyses are needed in addition to biochemical or immunohistochemical studies, or both. More discriminatory and sensitive antibodies to amylase isoenzymes, including the amy3 gene product, must also be found.
